These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2151722)

  • 1. Peptide-MHC interaction: a rational approach to vaccine design.
    Romagnoli P; Takacs B; Kilgus J; Pink JR; Sinigaglia F
    Int Rev Immunol; 1990; 6(1):61-73. PubMed ID: 2151722
    [No Abstract]   [Full Text] [Related]  

  • 2. Rules governing peptide-class II MHC molecule interactions.
    Hammer J; Nagy ZA; Sinigaglia F
    Behring Inst Mitt; 1994 Jul; (94):124-32. PubMed ID: 7998906
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin.
    Piesche M; Hildebrandt Y; Zettl F; Chapuy B; Schmitz M; Wulf G; Trümper L; Schroers R
    Hum Immunol; 2007 Jul; 68(7):572-6. PubMed ID: 17584578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple screening method for detecting bindings between oligopeptides and HLA-DR molecules on filter papers: possible application for mapping of putative helper T-cell epitopes on MSP1 of Plasmodium falciparum.
    Fu J; Hato M; Igarashi K; Suzuki T; Matsuoka H; Ishii A; Leafasia JL; Chinzei Y; Ohta N
    Microbiol Immunol; 2000; 44(4):249-57. PubMed ID: 10832968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.
    Singh R; Singh S; Sharma PK; Singh UP; Briles DE; Hollingshead SK; Lillard JW
    PLoS One; 2010 Feb; 5(2):e9432. PubMed ID: 20195541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The wild-type sequence (wt) p53(25-35) peptide induces HLA-DR7 and HLA-DR11-restricted CD4+ Th cells capable of enhancing the ex vivo expansion and function of anti-wt p53(264-272) peptide CD8+ T cells.
    Ito D; Albers A; Zhao YX; Visus C; Appella E; Whiteside TL; DeLeo AB
    J Immunol; 2006 Nov; 177(10):6795-803. PubMed ID: 17082593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.
    Berzofsky JA
    Biotechnol Ther; 1991; 2(1-2):123-35. PubMed ID: 1726961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines.
    Desombere I; Gijbels Y; Verwulgen A; Leroux-Roels G
    Clin Exp Immunol; 2000 Dec; 122(3):390-9. PubMed ID: 11122245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4+ T cells by at least four unrelated HLA-DR molecules.
    van der Burg SH; Kwappenberg KM; Geluk A; van der Kruk M; Pontesilli O; Hovenkamp E; Franken KL; van Meijgaarden KE; Drijfhout JW; Ottenhoff TH; Melief CJ; Offringa R
    J Immunol; 1999 Jan; 162(1):152-60. PubMed ID: 9886381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging principles for the design of promiscuous HLA-DR-restricted peptides: an example from the major bee venom allergen.
    Texier C; Pouvelle-Moratille S; Buhot C; Castelli FA; Pecquet C; Ménez A; Leynadier F; Maillère B
    Eur J Immunol; 2002 Dec; 32(12):3699-707. PubMed ID: 12516563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of primed human PBMC to synthetic peptides derived from hepatitis B virus envelope proteins: a search for promiscuous epitopes.
    Doh H; Roh S; Lee KW; Kim K
    FEMS Immunol Med Microbiol; 2003 Jan; 35(1):77-85. PubMed ID: 12589960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles.
    Doolan DL; Southwood S; Chesnut R; Appella E; Gomez E; Richards A; Higashimoto YI; Maewal A; Sidney J; Gramzinski RA; Mason C; Koech D; Hoffman SL; Sette A
    J Immunol; 2000 Jul; 165(2):1123-37. PubMed ID: 10878392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational and structural characteristics of peptides binding to HLA-DR molecules.
    Hill CM; Hayball JD; Allison AA; Rothbard JB
    J Immunol; 1991 Jul; 147(1):189-97. PubMed ID: 1711073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro.
    Jiang S; Tugulea S; Pennesi G; Liu Z; Mulder A; Lederman S; Harris P; Cortesini R; Suciu-Foca N
    Hum Immunol; 1998 Nov; 59(11):690-9. PubMed ID: 9796737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo.
    del Guercio MF; Alexander J; Kubo RT; Arrhenius T; Maewal A; Appella E; Hoffman SL; Jones T; Valmori D; Sakaguchi K; Grey HM; Sette A
    Vaccine; 1997 Mar; 15(4):441-8. PubMed ID: 9141216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic peptide interaction with MHC molecules: implications for the design of artificial vaccines.
    Berzofsky JA
    Semin Immunol; 1991 Jul; 3(4):203-16. PubMed ID: 1932704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets.
    Kropshofer H; Bohlinger I; Max H; Kalbacher H
    Biochemistry; 1991 Sep; 30(38):9177-87. PubMed ID: 1892827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces.
    Busch R; Strang G; Howland K; Rothbard JB
    Int Immunol; 1990; 2(5):443-51. PubMed ID: 1707655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A T-helper cell epitope overlaps a major B-cell epitope in human papillomavirus type 18 E2 protein.
    Lehtinen M; Stellato G; Hyöty H; Nieminen P; Vesterinen E; Paavonen J
    APMIS; 1992 Nov; 100(11):1022-6. PubMed ID: 1282020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally processed HLA-DR9/DR53 (DRB1*0901/DRB4*0101)-bound peptides.
    Futaki G; Kobayashi H; Sato K; Taneichi M; Katagiri M
    Immunogenetics; 1995; 42(4):299-301. PubMed ID: 7672826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.